Navigation Links
Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
Date:9/3/2007

Publication in September issue of Nature Methods Shows Application of

Bioinformatics tools to Identify The Most Powerful Matrix Attachment

Regions Applied to Boost Transgene Expression.

GENEVA, Switzerland, Aug. 21 /PRNewswire/ -- Researchers at Selexis SA and The University of Lausanne have reported the identification of novel high-performance Genetic Elements also known as matrix attachment regions (or MARs). Data are presented using these novel high-performance Genetic Elements for increased gene expression in mammalian cells. This research, published online August 5 and in the September issue of the journal Nature Methods, demonstrates that using bioinformatics analysis, researchers computed putative novel genetic elements from the human genome and confirmed through cloning experiments that these newly identified genetic elements could significantly and stably increase transgene expression in mammalian cells when compared to previously known genetic elements.

"Having the ability to identify and apply the most powerful genetic elements for use in the rapid development of high-performance cell lines further improves our already powerful technology and service offering," said Dr. Igor Fisch, CEO of Selexis. "Selexis has been applying this experimental approach to identify of our most productive Selexis Genetic Elements, and in fact, we are planning the introduction of a new class of Selexis Genetic Elements later this year. These new elements will be smaller and more powerful and are showing even greater performance in boosting antibody expression in CHO cells," continued, Dr. Fisch. "We are confident our existing and new licensees and cell line development customers will benefit from this new offering."

About Selexis:

Selexis is a privately held biotechnology company dedicated to the development of innovative technologies and expert services to speed the development of high performance mammalian cell lines. The
'/>"/>

SOURCE Selexis SA
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Wiley announces publication of Databasing the Brain
2. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
3. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
4. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
5. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
6. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
7. GlycoFi announces the first production of antibodies with human glycosylation in yeast
8. NHGRI announces new sequencing targets
9. CHAVI announces international search for genes affecting HIV response
10. NHGRI announces latest sequencing targets
11. MUHC announces a transplant first in Quebec

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...s about the health benefits of having a life partn... where amino acids known as cysteines are much mor...d up with other cysteines. , Now, researchers at... in Belgium, have discovered a new antioxidant sys...ppears in the Nov. 20 issue of the journal Scienc...
(Date:11/20/2009)...tists from the Marine Biogeochemistry and Geology ...ratory (NRL) organized and led a team of universit...n to initiate methane hydrate exploration in the B... sediment contribution to Arctic climate change. ,... as a research platform, three cross-shelf transec...
(Date:11/20/2009)...ial gene into yeast, researchers from Delft Univer...ee improvements in bioethanol production from agri...te and elimination of the major by-product glycero...ientific journal Applied and Environmental Microb...the yeast Saccharomyces cerevisiae from sugars obt...
Breaking Biology News(10 mins):Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2Delft breakthrough in bioethanol production from agricultural waste 2Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 1Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 2Advanced Instruments Introduces Next Generation Web Site 13665 1Advanced Instruments Introduces Next Generation Web Site 13665 2CareTech to Provide Web Services to Blessing Health System 55135 1CareTech to Provide Web Services to Blessing Health System 55135 2CareTech to Provide Web Services to Blessing Health System 55135 3CareTech to Provide Web Services to Blessing Health System 55135 4
...ter wi-fi, music over the internet, pitch percepti... favorite salmon, detecting dangerous swimmers, he...hm and movement disorders, visualizing the sound o...to save manatees from collisions with boats. , T...at the 156th meeting of the Acoustical Society of ...
...t Professor of Biomedical Engineering and Orthoped...oundation New Scholar in Aging by The Ellison Medi...s invited to nominate two faculty members to submi...ed for this award after an internal competition. N...s being granted out of 97 applicants. Dr. Alsberg ...
...screened known drugs and identified small molecule...nes, which can have dangerous side effects. This n... from fibroblasts, a general cell type that is abu...including skin. , The study was published in the ...e journal Cell Stem Cell. , "Our study shows fo...
Other Biology News:Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 2Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 3Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 4Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 5Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 6Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 7Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 8Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 9Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 10Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 11Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 12Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 13Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 14Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 15Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 16Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award 2Scripps research scientists identify compounds for stem-cell production from adult cells 2Scripps research scientists identify compounds for stem-cell production from adult cells 3
(Date:11/20/2009).... 20 Veridiam (www.veridiam.com) w...ompany category at the 2009 Workplace Excellence A...ociety for Human Resources Management and recogniz...ices. ,, Veridiam was one of nine winners, sele...es, honored at the recent awards ceremony. San Die...
(Date:11/20/2009)...OLM, November 20 Karolinska Develo...ent Fund (EIF) has entered into a,co-investment ag...ill be,managed by Karolinska Development and used ...e pharmaceutical and medical technology companies....nvestment fund. The agreement,represents EIF,s lar...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domini...he Role of Process Analytical Technology (PAT) in ...cember 1, 2009. , (PRWEB)...ess Analytical Technology (PAT) in Green Chemistry...cess Analytical Technology (PAT) case studies will...
(Date:11/19/2009)...19 Omeros Corporation (N... results for the third quarter ended September 30,...09, Omeros reported a net loss of $3.9 million, or...4 million, or $2.54 per share, for the same period...2009, the Company reported a net loss of $15.5 mil...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...-Guided IMRT to Spare Healthy .... 16 Doctors at cancer,treatment centers in the U...head and neck cancer using RapidArc(TM) radiothera...VAR ). RapidArc was used to deliver ultra-precise,...T) significantly faster,than was previously possib...
...uticals, Inc. (Nasdaq: BCRX ) today announced tha...resident of BioCryst, will present,a corporate upd...e in New,York on Tuesday, September 23, 2008 at 2:... cast of the presentation may be accessed on,the B...esentation will be,archived for 30 days., About B...
... MIGENIX Inc. (the,"Company" or "MIGENIX") (TSX: M...gs for infectious diseases, reports financial resu...rovides a corporate update on its programs,and oth... Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226; top...ted infections): Cadence Pharmaceuticals, Inc.,("C...
Other Biology Technology:Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck 2Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck 3BioCryst to Present at UBS 2008 Global Life Sciences Conference 2BioCryst to Present at UBS 2008 Global Life Sciences Conference 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 2MIGENIX Reports First Quarter Fiscal 2009 Financial Results 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 4MIGENIX Reports First Quarter Fiscal 2009 Financial Results 5MIGENIX Reports First Quarter Fiscal 2009 Financial Results 6MIGENIX Reports First Quarter Fiscal 2009 Financial Results 7MIGENIX Reports First Quarter Fiscal 2009 Financial Results 8MIGENIX Reports First Quarter Fiscal 2009 Financial Results 9MIGENIX Reports First Quarter Fiscal 2009 Financial Results 10MIGENIX Reports First Quarter Fiscal 2009 Financial Results 11
Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec
rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.
Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Biology Products: